Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa M Baumann Kreuziger

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Journal of Thrombosis and Thrombolysis|January 1, 2015
Management of anticoagulation and antiplatelet therapy in patients with left ventricular assist devicesLisa M Baumann Kreuziger
Leukemia & Lymphoma|April 12, 2013
The impact of Agent Orange exposure on presentation and prognosis of patients with chronic lymphocytic leukemiaLisa M Baumann Kreuziger, Gobind Tarchand, Vicki A Morrison
The Journal of Trauma and Acute Care Surgery|September 15, 2012
New anticoagulants: A concise reviewLisa M Baumann Kreuziger, Colleen T Morton, David J Dries
Leukemia Research|January 26, 2007
An MLL-SEPT9 fusion and t(11;17)(q23;q25) associated with de novo myelodysplastic syndromeLisa M Baumann Kreuziger, Julie Cliff Porcher, Rhett P Ketterling, et al.
Biomed Research International|August 20, 2014
Management of the bleeding patient receiving new oral anticoagulants: a role for prothrombin complex concentratesLisa M Baumann Kreuziger, Joseph C Keenan, Colleen T Morton, et al.
British Journal of Haematology|June 16, 2016
Blocking inhibition of prothrombinase by tissue factor pathway inhibitor alpha: a procoagulant property of heparinsJeremy P Wood, Lisa M Baumann Kreuziger, Umesh R Desai, et al.
European Journal of Haematology|March 11, 2011
Lack of efficacy of pyridoxine (vitamin B6) treatment in acquired idiopathic sideroblastic anaemia, including refractory anaemia with ring sideroblastsLisa M Baumann Kreuziger, Alexandra P Wolanskyj, Curtis A Hanson, et al.
Blood Advances|June 6, 2017
Reduced Prothrombinase Inhibition by Tissue Factor Pathway Inhibitor Contributes to the Factor V Leiden Hypercoagulable StateJeremy P Wood, Lisa M Baumann Kreuziger, Paul E R Ellery, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 1, 2014
Monitoring anticoagulation in patients with an unreliable prothrombin time/international normalized ratio: factor II versus chromogenic factor X testingLisa M Baumann Kreuziger, Yvonne H Datta, Andrew D Johnson, et al.
Annals of Cardiac Anaesthesia|October 18, 2019
Adequacy of hemostatic resuscitation improves therapeutic efficacy of recombinant activated factor VII and reduces reexploration rate for bleeding in postoperative cardiac surgery patients with refractory hemorrhageJoel T Feih, Janelle J Juul, Joseph R G Rinka, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Journal of Thrombosis and Thrombolysis|January 1, 2015
Management of anticoagulation and antiplatelet therapy in patients with left ventricular assist devicesLisa M Baumann Kreuziger
Leukemia & Lymphoma|April 12, 2013
The impact of Agent Orange exposure on presentation and prognosis of patients with chronic lymphocytic leukemiaLisa M Baumann Kreuziger, Gobind Tarchand, Vicki A Morrison
The Journal of Trauma and Acute Care Surgery|September 15, 2012
New anticoagulants: A concise reviewLisa M Baumann Kreuziger, Colleen T Morton, David J Dries
Leukemia Research|January 26, 2007
An MLL-SEPT9 fusion and t(11;17)(q23;q25) associated with de novo myelodysplastic syndromeLisa M Baumann Kreuziger, Julie Cliff Porcher, Rhett P Ketterling, et al.
Biomed Research International|August 20, 2014
Management of the bleeding patient receiving new oral anticoagulants: a role for prothrombin complex concentratesLisa M Baumann Kreuziger, Joseph C Keenan, Colleen T Morton, et al.
British Journal of Haematology|June 16, 2016
Blocking inhibition of prothrombinase by tissue factor pathway inhibitor alpha: a procoagulant property of heparinsJeremy P Wood, Lisa M Baumann Kreuziger, Umesh R Desai, et al.
European Journal of Haematology|March 11, 2011
Lack of efficacy of pyridoxine (vitamin B6) treatment in acquired idiopathic sideroblastic anaemia, including refractory anaemia with ring sideroblastsLisa M Baumann Kreuziger, Alexandra P Wolanskyj, Curtis A Hanson, et al.
Blood Advances|June 6, 2017
Reduced Prothrombinase Inhibition by Tissue Factor Pathway Inhibitor Contributes to the Factor V Leiden Hypercoagulable StateJeremy P Wood, Lisa M Baumann Kreuziger, Paul E R Ellery, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 1, 2014
Monitoring anticoagulation in patients with an unreliable prothrombin time/international normalized ratio: factor II versus chromogenic factor X testingLisa M Baumann Kreuziger, Yvonne H Datta, Andrew D Johnson, et al.
Annals of Cardiac Anaesthesia|October 18, 2019
Adequacy of hemostatic resuscitation improves therapeutic efficacy of recombinant activated factor VII and reduces reexploration rate for bleeding in postoperative cardiac surgery patients with refractory hemorrhageJoel T Feih, Janelle J Juul, Joseph R G Rinka, et al.
Pageof 2